Project Grant R01AI198530
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $599,642 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California Santa Cruz, effective May 5, 2026, with a completion date of April 30, 2031. The research initiative focuses on elucidating the mechanisms by which flagellar accessory proteins enhance bacterial motility, cellular responses, and infection capability in Helicobacter...
- Federal Project Grant Award Summary Yale University received a $735,631 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026 through March 31, 2031. The award supports fundamental and translational research investigating the origin, development, and functional properties of a distinct population of CX3CR1+ neutrophils—specialized immune cells that differ from...
- Federal Project Grant Award Summary Yale University received a $778,828 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 6, 2026, with a completion date of March 31, 2031. The award supports research into novel loss-of-function gene variants in ZFYVE21 and their role in dysregulating innate immunity. The research will employ a multidisciplinary team approach combining in...
- Federal Grant Award Summary Yale University received a $2.54 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 3, 2025, with completion targeted for August 31, 2029. The award supports fundamental research investigating novel mechanisms of protein homeostasis mediated by the molecular chaperone DnaK, an HSP70 (heat shock protein 70) chaperone in bacterial...
- Federal Project Grant Award Summary Yale University received a $3.26 million Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025, through July 31, 2029. The award funds research to elucidate molecular mechanisms of Mycobacterium tuberculosis (MTB) cell envelope assembly, with the goal of identifying drug synergy opportunities to enhance antibiotic efficacy. The...
- Federal Project Grant Award Summary Yale University received a $461,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 10, 2025, with a completion date of June 30, 2027. The project delivers research services focused on single-cell phenotyping methodologies to advance tuberculosis (TB) drug discovery. The research team will identify subcellular environments associated with...
- Federal Grant Award Summary Yale University received a $453,629 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 8, 2025, with completion targeted for June 30, 2027. The grant supports development and application of PHAGE-SEQ, a high-throughput technology combining phage display of nanobodies (VHH recognition domains derived from camelid heavy chain-only immunoglobulins)...
- Federal Project Grant Award Summary Yale University received a $2,685,326 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded July 7, 2025, with a completion date of June 30, 2029. The award supports biomedical research investigating the regulation of neutrophil plasticity, heterogeneity, and functional ambivalency by Wnt5 proteins in the context of colitis. The research focuses on...
- Federal Project Grant Award Summary Yale University received a $792,513 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 8, 2026, with completion targeted for March 31, 2031. This award supports research investigating serotype re-emergence and vaccine impact in the context of next-generation pneumococcal conjugate vaccines (PCVs). The research will deliver mathematical...
- Federal Project Grant Award Summary Yale University received a $100,228 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded October 9, 2026, with completion targeted for June 30, 2029. This research project focuses on characterizing hookworm glycoproteins and their roles in parasite immunopathogenesis. The research will identify and characterize glycosylated proteins present...
The National Institute of Allergy and Infectious Diseases awarded Yale University a Project Grant totaling $710,638 (Award Date: May 1, 2026; Completion Date: April 30, 2031) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct fundamental research on sheathed flagellar structures in Helicobacter pylori. The research will employ cryo-electron tomography (cryo-ET) and cryo-electron microscopy (cryo-EM) combined with biochemical, microscopy, and genetic approaches to characterize accessory proteins and their roles in flagellar assembly and function, with three primary objectives: determining how the spoke-ring-cage network assembles to enable optimal motility; identifying how outer membrane-associated accessories facilitate membrane remodeling and sheath formation; and deciphering flagellar assembly and immune evasion mechanisms. This research addresses a significant public health challenge, as H. pylori colonizes approximately half the global population and represents the major pathogenic factor for peptic ulcer disease, chronic gastritis, and gastric cancer. The anticipated outcomes of this project include critical molecular-level insights into the unique adaptations of sheathed flagella and identification of potential therapeutic targets for developing novel antibacterial compounds that inhibit bacterial motility and pathogenesis. The work will be performed at Yale University's location in West Haven, Connecticut.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $710.6k | 5/1/26 |